Formula Growth Ltd’s Neogenomics Inc Position
Does Formula Growth Ltd own Neogenomics Inc (NEO)? Not currently — the last reported position was 199.1K shares worth $3M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q4 2023
Shares
199.1K
% of Portfolio
+1.03%
Quarters Held
19
position exited
Position History NEO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2023 | 199.1K | $3M | +1.03% |
| Q3 2023 | 208.9K | $3M | +0.88% |
| Q2 2023 | 210.7K | $3M | +1.08% |
| Q1 2023 | 280.7K | $5M | +1.57% |
| Q4 2022 | 180.3K | $2M | +0.47% |
| Q3 2022 | 270.3K | $2M | +0.66% |
| Q2 2022 | 53.3K | $434,000 | +0.12% |
| Q1 2022 | 63.3K | $769,000 | +0.15% |
| Q4 2021 | 63.3K | $2M | +0.38% |
| Q3 2021 | 80.0K | $4M | +0.55% |
| Q2 2021 | 80.0K | $4M | +0.50% |
| Q1 2021 | 80.0K | $4M | +0.55% |
| Q4 2020 | 80.0K | $4M | +0.72% |
| Q3 2020 | 90.0K | $3M | +0.62% |
| Q2 2020 | 95.0K | $3M | +0.50% |
| Q1 2020 | 95.0K | $3M | +0.50% |
| Q4 2019 | 100.0K | $3M | +0.37% |
| Q3 2019 | 100.0K | $2M | +0.29% |
| Q2 2019 | 100.0K | $2M | +0.31% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Formula Growth Ltd’s full portfolio or all institutional holders of NEO.